We are live on
!
Find out more
NC
Noked Capital Portfolio holdings
AUM
$946K
1-Year Est. Return
17.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
-17.1%
3 Year Est. Return
+197.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$95.9M
AUM Growth
-$23.5M
(-20%)
Cap. Flow
-$28.3M
Cap. Flow
% of AUM
-29.45%
Top 10 Holdings %
Top 10 Hldgs %
67.85%
Holding
98
New
41
Increased
4
Reduced
17
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SolarEdge
SEDG
|
+$20.2M |
| 2 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
+$2.2M |
| 3 |
Delek US
DK
|
+$919K |
| 4 |
Gilat Satellite Networks
GILT
|
+$899K |
| 5 |
Viatris
VTRS
|
+$893K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ituran Location and Control
ITRN
|
+$14.9M |
| 2 |
Teva Pharmaceuticals
TEVA
|
+$11.8M |
| 3 |
Caesarstone
CSTE
|
+$11.2M |
| 4 |
MLNX
Mellanox Technologies, Ltd.
MLNX
|
+$8.98M |
| 5 |
iShares MSCI ACWI ETF
ACWI
|
+$6.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.35% |
| 2 | Healthcare | 24.19% |
| 3 | Energy | 10.34% |
| 4 | Financials | 7.72% |
| 5 | Communication Services | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
SolarEdge
SEDG
$2.74B
| $28.1M | 29.28% |
745,269
+505,076
| +210% | +$20.2M |
|
|
2
Teva Pharmaceuticals
TEVA
$40.2B
| $12.1M | 12.62% |
771,975
-667,300
| -46% | -$11.8M |
|
|
3
Delek US
DK
$4.05B
| $8.46M | 8.82% |
232,400
+27,000
| +13% | +$919K |
|
|
4
Viatris
VTRS
$20.5B
| $5.67M | 5.91% |
200,000
+30,605
| +18% | +$893K |
|
|
MSGN
5
DELISTED
MSG Networks Inc.
MSGN
| $3.03M | 3.16% |
139,400
| – | – |
|
|
ITMR
6
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $2.07M | 2.15% |
+178,011
| New | +$2.2M |
|
7
Apple
AAPL
$4.46T
| $1.93M | 2.02% |
40,700
-8,000
| -16% | -$339K |
|
8
Microsoft
MSFT
$3.62T
| $1.91M | 1.99% |
16,200
| – | – |
|
9
Chevron
CVX
$385B
| $985K | 1.03% |
8,000
| – | – |
|
|
10
Gilat Satellite Networks
GILT
$883M
| $840K | 0.88% |
+100,000
| New | +$899K |
|
11
Bank of America
BAC
$438B
| $828K | 0.86% |
30,000
| – | – |
|
12
US Bancorp
USB
$99.6B
| $819K | 0.85% |
17,000
| – | – |
|
|
RADA
13
DELISTED
Rada Electronic Industries Ltd
RADA
| $751K | 0.78% |
255,319
| – | – |
|
14
Wells Fargo
WFC
$266B
| $725K | 0.76% |
15,000
| – | – |
|
15
Duke Energy
DUK
$96.9B
| $693K | 0.72% |
+7,700
| New | +$679K |
|
|
BREW
16
DELISTED
Craft Brew Alliance, Inc.
BREW
| $675K | 0.7% |
48,302
+8,095
| +20% | +$128K |
|
17
Simon Property Group
SPG
$74.3B
| $674K | 0.7% |
+3,700
| New | +$658K |
|
18
Meta Platforms (Facebook)
META
$1.5T
| $667K | 0.7% |
+4,000
| New | +$636K |
|
19
Walt Disney
DIS
$170B
| $666K | 0.69% |
+6,000
| New | +$671K |
|
20
eBay
EBAY
$47.6B
| $650K | 0.68% |
+17,500
| New | +$607K |
|
21
Hershey
HSY
$35.7B
| $632K | 0.66% |
5,500
-3,500
| -39% | -$381K |
|
22
Broadcom
AVGO
$1.87T
| $631K | 0.66% |
+21,000
| New | +$569K |
|
23
Royal Bank of Canada
RY
$292B
| $605K | 0.63% |
+6,000
| New | +$454K |
|
24
Johnson & Johnson
JNJ
$613B
| $601K | 0.63% |
4,300
-1,400
| -25% | -$188K |
|
25
Toronto Dominion Bank
TD
$200B
| $580K | 0.6% |
+8,000
| New | +$442K |
|
Similar funds
MC
GAM
NP
TGI
IVAV
VM
SC
CL
Noked Capital's Q1 2019 Portfolio in Review
As of Q1 2019, Noked Capital held 98 positions worth $95.9M, down 20% from $119M the previous quarter. Its ten largest holdings account for 68% of the portfolio.
Noked Capital withdrew a net $28.3M in Q1 2019, closing 27 positions and reducing 17 holdings. Its most notable exit was Ituran Location and Control, an estimated $14.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 33% a quarter earlier, followed by Healthcare and Energy.
Against the trend, Noked Capital opened a new position in Itamar Medical Ltd. American Depository Shares worth $2.07M.
- Noked Capital's largest Q1 2019 buy was Itamar Medical Ltd. American Depository Shares: 178,011 shares worth $2.07M.
- Noked Capital added most to SolarEdge in Q1 2019, an estimated $20.2M increase.
- Noked Capital's biggest Q1 2019 reduction was Teva Pharmaceuticals, cutting an estimated $11.8M.
- Noked Capital fully exited Ituran Location and Control in Q1 2019, selling an estimated $14.9M.
- Noked Capital's ten largest holdings make up 68% of its $95.9M portfolio in Q1 2019.
- Noked Capital opened 41 new positions and closed 27 in Q1 2019.
- Noked Capital's portfolio value fell 20% quarter-over-quarter to $95.9M.
Based on Noked Capital's 13F filing for Q1 2019, filed 13 May 2019.